explore -WSS

explore

author：comprehensive 2025-08-21 08:27:13 - browse：857

Photo of an arrangement of aspirin pills — Patrick Sison/AP

Low-dose aspirin led to a reduction in liver fat among patients with metabolic-associated liver disease, a small study out of Boston found.

The clinical trial, led by Tracey Simon of Massachusetts General Hospital and Harvard Medical School, compared two groups of patients with metabolic dysfunction-associated steatotic liver disease, or MASLD. One group was given baby aspirin daily for six months, while the other received a placebo pill. At the end of the study period, the aspirin group had reduced hepatic fat content while the placebo group had higher fat buildup.

MASLD (formerly known as non-alcoholic fatty liver disease) is a growing health threat, with 1 in 3 Americans having a troublesome amount of fat in their liver. The lipid buildup feeds into a toxic cycle of inflammation, tissue damage and, ultimately, irreversible scarring.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Biogen walks away from Aduhelm, years after polarizing approval

WSS

How to increase colonoscopy rates? Looks like an AI can help

Letters to First Opinion on caregivers, digital health, and more

ASCO: AstraZeneca says CAR

Woman returns to dialysis after doctors remove transplanted pig kidney

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

ASCO: AstraZeneca says CAR

explore

explore

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Let's speed up science by embracing open access publishing

BioMarin wins approval for gene therapy to treat hemophilia A

FDA's Pazdur wants cancer trials to range beyond China alone

Affirmative action in medical school literally saved lives

Letters to First Opinion on caregivers, digital health, and more

At least 13 dead in Texas as scorching temps continue

Health Care Service Corp to buy Cigna Medicare Advantage plans

Medical leaders decry Supreme Court decision on affirmative action

See how much Covid

Wikipedia

Ultragenyx gene therapy for rare liver ailment succeeds in late

Wegovy leads to weight loss. Can it treat depression, too?

With trial win, GSK could get blood cancer drug back on market

Zyn nicotine pouches become unlikely player in latest culture war

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Ultragenyx gene therapy for rare liver ailment succeeds in late

explore

focus

focus

focus